Selecta Biosciences

Selecta Biosciences

Pioneering RNA cell therapy for autoimmune disease.

Launch date
Employees
Market cap
$358m
Enterprise valuation
$145m (Public information from Sep 2024)
Watertown Massachusetts (HQ)
Authorizing premium user...